PrimaryCareNOW | Begin CME/CE Conference | Pri-Med

Thank you to all who joined us live for PrimaryCareNOW on Thursday-Friday, November 18–19. If you were not able to join us live, some sessions have been recorded and are available below. 

Upcoming Virtual Conferences 
Please join us for the final PrimaryCareNOW of the year on Thursday, December 16.
Pri-Med has more virtual education planned. View our upcoming virtual conference schedule.

Plan Your CME/CE Experiences

 

Agenda

  CME/CE Accredited Session

Non-CME/CE Session
Sponsored by Industry

Click For Session Details
Session Times Listed in ET

8–9am ET    CME/CE Accredited Session

Hot Topics

Curbside Consults: Top Questions from PCPs on HIV and Acne/Rosacea 

Howard Libman, MD | Jacob Levitt, MD, FAAD

 

What do primary care providers need to know about HIV and Acne/Rosacea? Join expert faculty as they review important questions they get asked about these topics!

Howard Libman, MD

Attending Physician, Division of General Medicine and Primary Care, Beth Israel Deaconess Medical Center, Professor of Medicine, Emeritus, Harvard Medical School, Boston, MA

Jacob Levitt, MD, FAAD

Professor and Vice Chairman, Department of Dermatology, Mount Sinai Medical Center, New York, NY

9:10–10:10am ET    CME/CE Accredited Session

Psychiatry

Treatment Escalation for Patients With Major Depressive Disorder

Pamela Kushner, MD, FAAFP | Jeffrey Rado, MD, MPH, FAPA

 

Have you ever been stuck wondering what the best next steps are for your patients with major depressive disorder (MDD) who do not respond fully to initial pharmacotherapy? This session will provide evidence-based strategies for recognizing and treating patients with MDD who suffer from incompletely treated MDD—a circumstance that is more common that many realize, and which has serious health and psychosocial consequences. You will leave this session better equipped to identify these patient and formulate individualized plans to advance their care beyond initial monotherapy.

Pamela Kushner, MD, FAAFP

Clinical Professor, Director, Kushner Wellness, UC Irvine Medical Center, Orange, CA

Jeffrey Rado, MD, MPH, FAPA

Associate Professor, Northwestern University Feinberg School of Medicine, Chicago, IL

Supported by Otsuka America Pharmaceutical, Inc. and Lundbeck

10:20–11:05am ET    Non-CME Industry Theater

Endocrinology

Shifting Perspectives: How Do You Choose the Next Oral Therapy for T2D?

Doron Schneider, MD, FACP

 

Review the pathophysiology of T2D and the recommendations from relevant associations on the oral treatment options that should be used after metformin in the T2D treatment plan. Discuss head-to-head data for a once-daily treatment option from pivotal glycemic control trials and safety data from a cardiovascular outcomes trial, followed by dosing and administration information.

Doron Schneider, MD, FACP

Vice President, Population Health Services, Tandigm Health West Conshohocken, PA

Sponsored by Novo Nordisk Inc.

10:20–11:05am ET    Non-CME Industry Theater

Pulmonology

Evaluating the Use of Oral Corticosteroids in Asthma: Benefits and Risks

Danielle Dolan, RN, MS, FNP-C, AE-C

 

  • Review updated treatment paradigms for severe asthma.
  • Evaluate the benefit-risk of oral corticosteroid use in severe uncontrolled asthma and the need for OCS stewardship.
  • Discuss the role of biologics as a preferred treatment option for severe asthma management.

Danielle Dolan, RN, MS, FNP-C, AE-C

Medical Science Liaison, Respiratory & Immunology, New Jersey

Sponsored by AstraZeneca Pharmaceuticals, LP

11:15am–12:15pm ET    CME/CE Accredited Session

Endocrinology

A Holistic Approach to Diabetes Care: Reducing HbA1c and Weight with Emerging Pharmacotherapies

Silvio E. Inzucchi, MD | Anne Peters, MD

 

This educational activity will review strategies to improve glycemic and extra-glycemic outcomes in patients with type 2 diabetes and explore the role of agents that target GIP and GLP-1 in the management of type 2 diabetes and obesity.

Silvio E. Inzucchi, MD

Professor of Medicine, Clinical Chief, Endocrinology, Medical Director, Yale Diabetes Center, Yale School of Medicine, Yale-New Haven Hospital, New Haven, CT

Anne Peters, MD

Professor of Clinical Medicine, Keck School of Medicine of USC, Los Angeles, CA

Supported by Lilly. For further information concerning Lilly grant funding visit www.lillygrantoffice.com.

12:25–1:25pm ET    CME/CE Accredited Session

Oncology

Early Action in HCC: Supporting the Patient Journey in Primary Care

Amit Singal, MD, MS | Ghassan Abou-Alfa, MD, MBA

 

Although hepatocellular carcinoma (HCC) screening can improve survival for patients, it is underused in clinical practice. Join two faculty experts as they discuss the urgency for early identification of HCC in primary care, and learn about the changing epidemiology of HCC and how primary care providers can support patients during their journey. This program also features patient/caregiver videos and interactive Q&A sessions.

Amit Singal, MD, MS

Professor of Medicine, Willis C. Maddrey Chair in Liver Disease, Chair of Hepatology, Medical Directory of Liver Tumor Program, UT Southwestern Medical Center, Dallas, TX

Ghassan Abou-Alfa, MD, MBA

Attending Physician, Memorial Sloan-Kettering Cancer Center, Professor of Medicine, Weill Medical College, Cornell University, New York, NY

Supported by an educational grant from Genentech, a member of the Roche Group.

1:35–2:20pm ET    Non-CME Industry Theater

Urology

Discover the Impact of GEMTESA: A Selective β3-Adrenergic Agonist for Effective OAB Treatment

Matt T Rosenberg, MD

 

 

Matt T Rosenberg, MD

Consultant of Urovant Sciences

Sponsored by Urovant Sciences

1:35–2:20pm ET    Non-CME Industry Theater

Neurology

Two Oral CGRP Antagonists for the Treatment of Migraine

Alan M. Rapoport, MD

 

This product theater will focus on the commitment AbbVie has to migraine patients by highlighting two oral CGRP receptor antagonists that directly block CGRP.

Alan M. Rapoport, MD

Clinical Professor of Neurology, at The David Geffen School of Medicine at UCLA

Sponsored by AbbVie

2:30–3:30pm ET    CME/CE Accredited Session

Pulmonology

Curbside Consults: Top Questions from PCPs in Asthma and COPD 

Sunjay R. Devarajan, MD | Nicola Hanania, MD, MS, FCCP, FACP, FRCP (C)

 

What do primary care providers need to know about asthma and COPD? Join expert faculty as they review important questions they get asked about these topics!

Sunjay R. Devarajan, MD

Professor Division of Pulmonary & Critical Care, Baylor College of Medicine, Houston, TX

Nicola Hanania, MD, MS, FCCP, FACP, FRCP (C)

Director, Airways Clinical Research Center, Baylor College of Medicine, Houston, TX, Interim Chief, Section of Pulmonary, Critical Care and Sleep Medicine, Ben Taub Hospital, Houston, TX

3:40–4:40pm ET    CME/CE Accredited Session

LGBTQ Health

 

Learn about the dosing, effects, risks and monitoring of various hormone treatment regimens for transgender and non-binary patients.

Michael Irwig, MD

Associate Professor, Harvard Medical School, Director of Transgender Medicine,, Beth Israel Deaconess Medical Center

4:50–5:35pm ET    Non-CME Industry Theater

Cardiology

Clinical Considerations in Coronary Artery Disease

Ted Okerson, MD, FACP, FACE

 

  • Understand the disease burden and pathophysiology for acute ischemic stroke (AIS), and appreciate the underlying alterations in platelet physiology and phenotype in the context of AIS or high-risk transient ischemic attack (TIA).
  • Learn about the use of BRILINTA in patients with AIS and high-risk TIA and the differentiation of P2Y12 inhibitor use in this patient population.
  • Appreciate the evidence and indications for BRILINTA across the spectrum of atherosclerotic and atherothrombotic disease by understanding the BRILINTA Pivotal Trials and the recently published THALES Trial.

Ted Okerson, MD, FACP, FACE

Dr. Okerson currently serves as a Sr. Field Physician within the Biopharmaceuticals US Medical Team for AstraZeneca’s Division of Cardiovascular and Metabolic Diseases. Dr. Okerson has a diverse medical and scientific background, with over 15 years of full-time clinical practice and leadership experience. For the past twenty years, he has exemplified a successful transition to industry, working as a Medical Director in various aspects of the pharmaceutical industry from clinical trial design to late phase clinical development and medical affairs for various well-known companies. In his current role, Dr. Okerson educates HCPs, works across specialties for internal collaborations, and strives to improve patient care.

Sponsored by AstraZeneca Pharmaceuticals, LP

8–9am ET    CME/CE Accredited Session

Urgent Care

Challenging Cases in Urgent Care  

R. Michelle Schmidt, MD, MPH

 

Throughout this 60-minute session, learners will review cases that are commonly seen in an urgent care setting, understand problems that are frequently encountered in an urgent care, and know how to best approach these issues to benefit both the health care provider and the patient. Participants will learn when patients may avoid a trip to the urgent care center and when providers should refer to a specialist.  Additionally, learners will review cases that highlight certain problems that primary care providers may encounter in their practices.

R. Michelle Schmidt, MD, MPH

Assistant Professor, Section of General Medicine, Baylor College of Medicine, Houston, TX

9:10–10:10am ET    CME/CE Accredited Session

Endocrinology

Digital Technology: The Present and Future of Diabetes Care 

Diana Isaacs, PharmD, BCPS, BC-ADM, BCACP, CDCES | Lucia M. Novak, MSN, ANP-BC, BC-ADM, CDTC

 

You know that insulin therapy is an important tool in improving quality of life and health outcomes for your patients with diabetes, but are you familiar with the expanding array of diabetes technology that can play an important role in improving insulin delivery and management? Do you know how to optimally use these tools? After this activity, you’ll be able to interpret continuous glucose monitoring data to improve time-in-range, minimize hypoglycemia, and reduce postprandial glycemic excursions. Don’t miss this opportunity to learn how to incorporate diabetes technology into clinical practice to optimize insulin management, bolster patients’ confidence in self-management of their diabetes, and, ultimately, improve health outcomes.

Diana Isaacs, PharmD, BCPS, BC-ADM, BCACP, CDCES

CGM & Remote Monitoring Program Coordinator, Cleveland Clinic Diabetes Center, Cleveland, OH

Lucia M. Novak, MSN, ANP-BC, BC-ADM, CDTC

Board Certified Adult Health and Advanced Diabetes Management, Nurse Practitioner, President and Owner, Diabetes Consulting Services, Co-Executive Director, Capital Health & Metabolic Center, Capital Diabetes & Endocrine Associates, Silver Spring, MD

Supported by Novo Nordisk Inc.

10:20–11:05am ET    Non-CME Industry Theater

Pulmonology

Rethinking the Role of Nebulization in the Maintenance Treatment of COPD

Aaron P. Milstone, MD, FCCP

 

Join us to learn about a maintenance therapy for the treatment of COPD.

Aaron P. Milstone, MD, FCCP

Medical Director, Williamson Pulmonary and Sleep Medicine, Williamson Medical Group

Sponsored by Viatris and Theravance Biopharma

10:20–11:05am ET    Non-CME Industry Theater

Pulmonology

Treating EPI: EPI in Clinical Practice

Douglas Adler, MD

 

Discuss the diagnosis of Exocrine Pancreatic Insufficiency (EPI) and the treatment with CREON.

Douglas Adler, MD

Sponsored by AbbVie

11:15am–12:15pm ET    CME/CE Accredited Session

Endocrinology

Incretin-Based Multiagonist Therapy: Emerging Treatment for Obesity and Diabetes 

Jennifer B. Green, MD | Robert F. Kushner, MD, FACP

 

Given that 9 out of 10 people with diabetes also suffer from overweight or obesity, it is important for PCPs to take a holistic approach to treatment rather than solely a glucocentric approach. This activity helps you understand the benefits of weight loss as a key therapeutic strategy in the treatment of type 2 diabetes mellitus (T2DM) and the importance of early treatment intensification to improve long-term outcomes. You’ll also walk away from this session with a firm grasp of the role incretins play in the pathophysiology of T2DM, obesity, and other metabolic conditions and the latest clinical trial evidence behind incretin-based agents.

Jennifer B. Green, MD

Associate Professor of Medicine, Department of Medicine, Division of Endocrinology, Faculty Member, Duke Clinical Research Institute, Duke University Medical Center, Durham, NC

Robert F. Kushner, MD, FACP

Professor of Medicine, Northwestern University Feinberg School of Medicine, Chicago, IL

Supported by Lilly. For further information concerning Lilly grant funding visit www.lillygrantoffice.com.

12:25–1:25pm ET    CME/CE Accredited Session

Gastroenterology

Managing Myths and Misconceptions about Chronic Idiopathic Constipation and Irritable Bowel Syndrome with Constipation

Philip Schoenfeld, MD, MSEd, MSc

 

This activity will provide an evidence-based approach to the diagnosis and management of chronic idiopathic constipation (CIC) and irritable bowel syndrome with constipation (IBS-C), with minimal diagnostic testing. The faculty will describe evidence-based treatment guidelines and discuss the efficacy of over-the-counter and prescription agents prioritized within the guidelines. This will help you navigate the progress from patient education to diet plus over-the-counter agents to prescription agents.

Philip Schoenfeld, MD, MSEd, MSc

Chief (Emeritus) - Gastroenterology Section, John D. Dingell VA Medical Center, Detroit, MI

Supported by an educational grant from AbbVie Inc. and Takeda Pharmaceuticals U.S.A., Inc..

1:35–2:20pm ET    Non-CME Industry Theater

Cardiology

Clinical Insights in Reducing Major Thrombotic Vascular Events in Patients With PAD

Suman M. Wasan, MD

 

Patients with peripheral artery disease (PAD), including patients after lower-extremity revascularization due to symptomatic PAD are risk for major thrombotic vascular events. This lecture will discuss an approach to reducing the risk of these events.

Suman M. Wasan, MD

Sponsored by Janssen Pharmaceuticals, Inc.

1:35–2:20pm ET    Non-CME Industry Theater

Pulmonology

The Changing Treatment Landscape for Uncontrolled Asthma

Neil Skolnik, MD

 

This session will use a case presentation to discuss the impact of uncontrolled asthma and tools for assessing asthma control as well as asthma management. Learn to identify ways to customize management of uncontrolled asthma by exploring medication options for appropriate patients.

Neil Skolnik, MD

Neil Skolnik, MD

Professor of Family and Community Medicine, Sidney Kimmel Medical College, Thomas Jefferson University, Associate Director, Family Medicine Residency Program, Abington Jefferson Health

Sponsored by GlaxoSmithKline

2:30–3:30pm ET    CME/CE Accredited Session

Hot Topics

Curbside Consults: Top Questions from PCPs on SSRI and Dementia 

Jeffrey Rado, MD, MPH, FAPA | Katherine E. Galluzzi, DO, CMD, FACOFP

 

What do primary care providers need to know about SSRI and dementia? Join expert faculty as they review important questions they get asked about these topics!

Jeffrey Rado, MD, MPH, FAPA

Associate Professor, Northwestern University Feinberg School of Medicine, Chicago, IL

Katherine E. Galluzzi, DO, CMD, FACOFP

Professor and Chair, Department of Geriatrics, Philadelphia College of Osteopathic Medicine, Philadelphia, PA

3:40–4:40pm ET    CME/CE Accredited Session

Wellness

 

Nutrition research and recommendations are rapidly changing. Fill your toolbox with behavioral and food-driven action plans to answer your patients' toughest Nutrition and lifestyle issues. Updated recommendations for nutrition advice for IBS, intermittent fasting, popular diets, food intolerances, and more will be answered.

Bethany Doerfler, MS, RDN

Clinical Research Dietitian, Division of Gastroenterology & Hepatology, Northwestern University, Feinberg School of Medicine, Adjunct Faculty, Marciella School of Nursing, Loyola University, Chicago, IL

4:50–5:35pm ET    Non-CME Industry Theater

Rheumatology

Path To Diagnosis, Mapping Symptoms of Inflammatory Back Pain

Joy Schechtman, DO

 

  • Understand the causes and prevalence of chronic low back pain.
  • Differentiate inflammatory back pain (IBP) from mechanical back pain.
  • Learn the significance of IBP as a potential early symptom of ankylosing spondylitis (AS).
  • Learn the importance of referring patients with IBP to a rheumatologist in a timely manner.
 

Joy Schechtman, DO

Sponsored by AbbVie Inc.